<code id='9DAF937964'></code><style id='9DAF937964'></style>
    • <acronym id='9DAF937964'></acronym>
      <center id='9DAF937964'><center id='9DAF937964'><tfoot id='9DAF937964'></tfoot></center><abbr id='9DAF937964'><dir id='9DAF937964'><tfoot id='9DAF937964'></tfoot><noframes id='9DAF937964'>

    • <optgroup id='9DAF937964'><strike id='9DAF937964'><sup id='9DAF937964'></sup></strike><code id='9DAF937964'></code></optgroup>
        1. <b id='9DAF937964'><label id='9DAF937964'><select id='9DAF937964'><dt id='9DAF937964'><span id='9DAF937964'></span></dt></select></label></b><u id='9DAF937964'></u>
          <i id='9DAF937964'><strike id='9DAF937964'><tt id='9DAF937964'><pre id='9DAF937964'></pre></tt></strike></i>

          focus

          focus

          author:leisure time    Page View:14
          Doctor sitting at a crowded desk. -- first opinion coverage from STAT
          Adobe

          SAN FRANCISCO — If you learned anything about nonprofit hospitals on the first day of the J.P. Morgan Healthcare Conference, it’s that they’ve all but abandoned the prospect of making significant profit on patient care. Instead, they’re fully throwing their weight into other ways of making money — things like developing drugs or selling insurance.

          Making money outside of patient care — or “revenue diversification,” if you prefer industry jargon — has always made appearances on hospital slides at the annual investor conference in San Francisco. This year, though, hospital executives are projecting a sense of urgency around growing profit in other areas to make up for losing money on their bread and butter: taking care of patients in hospitals.

          advertisement

          “It used to be nice to have, but now it’s a must-have, especially for not-for-profit health systems,” Niyum Gandhi, the chief financial officer of Boston’s Mass General Brigham said in an interview with STAT after his presentation.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          Drug cartel violence flares in western Mexico after vigilante leader's killing
          Drug cartel violence flares in western Mexico after vigilante leader's killing

          ForensicmedicalexaminersworkatthescenewhereanunidentifiedmanwaskilledinApatzingan,Mexico,Sunday,July

          read more
          Dobbs anniversary: the lost opportunity of abortion as health care
          Dobbs anniversary: the lost opportunity of abortion as health care

          NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

          read more

          Penis shrinkage, a side effect of prostate cancer surgery, is temporary

          AdoctorperformsaroboticprostatectomyatUniversityofChicagoMedicalCenter.M.SpencerGreen/APIt’sbeencall